Screening methods for cytokine inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 7805, A61K 31445

Patent

active

059624779

ABSTRACT:
The present invention provides a number of screening methods for evaluatiing compounds capable of suppressing cytokine production either in vitro or in vivo. The methods generally involve stimulating the production of a cytokine in a cell, exposing a portion of the cells to a putative cytokine modulating agent and determining subsequent levels of cytokine production in the cells. Additionally, the present invention provides certain compounds identified by this method.

REFERENCES:
patent: 3275510 (1966-09-01), Magid et al.
patent: 3714159 (1973-01-01), Adriaan et al.
patent: 3789072 (1974-01-01), Bernstein
patent: 3884916 (1975-05-01), Janssen et al.
patent: 3914238 (1975-10-01), Soudijn et al.
patent: 3950537 (1976-04-01), DeBenneville et al.
patent: 3996214 (1976-12-01), Dajani et al.
patent: 3998832 (1976-12-01), Adelstein et al.
patent: 4012374 (1977-03-01), Wade et al.
patent: 4012393 (1977-03-01), Markos et al.
patent: 4013668 (1977-03-01), Adelstein et al.
patent: 4025652 (1977-05-01), Diamond et al.
patent: 4057549 (1977-11-01), Adelstein et al.
patent: 4060635 (1977-11-01), Diamond et al.
patent: 4066654 (1978-01-01), Adelstein et al.
patent: 4069223 (1978-01-01), Adelstein et al.
patent: 4072686 (1978-02-01), Adelkstein et al.
patent: 4115564 (1978-09-01), Diamond et al.
patent: 4116963 (1978-09-01), Adelstein et al.
patent: 4125531 (1978-11-01), Yen
patent: 4194045 (1980-03-01), Adelstein
patent: 4203920 (1980-05-01), Diamond et al.
patent: 4218454 (1980-08-01), DeGraw et al.
patent: 4238390 (1980-12-01), Meienhofer et al.
patent: 4269843 (1981-05-01), DeGraw et al.
patent: 4277605 (1981-07-01), Buyniski et al.
patent: 4326074 (1982-04-01), Diamond et al.
patent: 4326075 (1982-04-01), Diamond et al.
patent: 4328803 (1982-05-01), Pape
patent: 4371463 (1983-02-01), Pert et al.
patent: 4384000 (1983-05-01), Lanier
patent: 4407794 (1983-10-01), Roques et al.
patent: 4416886 (1983-11-01), Bernstein
patent: 4430327 (1984-02-01), Frederickson
patent: 4493848 (1985-01-01), LaHann et al.
patent: 4517295 (1985-05-01), Bracke et al.
patent: 4533739 (1985-08-01), Pitzele et al.
patent: 4626539 (1986-12-01), Aungst et al.
patent: 4749706 (1988-06-01), Lawson et al.
patent: 4824853 (1989-04-01), Wals et al.
patent: 4870084 (1989-09-01), Eggler et al.
patent: 4871750 (1989-10-01), Roberts
patent: 4892735 (1990-01-01), Harrap
patent: 4897260 (1990-01-01), Ros et al.
patent: 4898873 (1990-02-01), Wals et al.
patent: 4917896 (1990-04-01), Peck et al.
patent: 4990521 (1991-02-01), Van Daele et al.
patent: 5039642 (1991-08-01), Chrobaczek
patent: 5069909 (1991-12-01), Sharma et al.
patent: 5100903 (1992-03-01), Lalinde et al.
patent: 5109135 (1992-04-01), D'Ambra et al.
patent: 5112596 (1992-05-01), Malfroy-Camine
patent: 5116847 (1992-05-01), Gilbert et al.
patent: 5116868 (1992-05-01), Chen et al.
patent: 5143938 (1992-09-01), Calvet et al.
patent: 5149538 (1992-09-01), Granger et al.
patent: 5202130 (1993-04-01), Grant et al.
patent: 5214080 (1993-05-01), Iwamura et al.
patent: 5229127 (1993-07-01), McKinzie
patent: 5236947 (1993-08-01), Calvet et al.
patent: 5240932 (1993-08-01), Morimoto et al.
patent: 5242944 (1993-09-01), Park et al.
patent: 5248505 (1993-09-01), Garwin
patent: 5273056 (1993-12-01), McLaughlin et al.
patent: 5273751 (1993-12-01), Dubroff
patent: 5278126 (1994-01-01), Katano et al.
patent: 5282851 (1994-02-01), Jacob-LaBarre
patent: 5286751 (1994-02-01), Sunshine et al.
patent: 5292362 (1994-03-01), Bass et al.
patent: 5300648 (1994-04-01), Emonds-Alt et al.
patent: 5312899 (1994-05-01), Schiller
patent: 5345943 (1994-09-01), Hargreaves et al.
patent: 5354863 (1994-10-01), Dappen et al.
patent: 5366979 (1994-11-01), Lawson
patent: 5369131 (1994-11-01), Poli et al.
patent: 5384124 (1995-01-01), Courteille et al.
patent: 5387688 (1995-02-01), Feldman et al.
patent: 5403867 (1995-04-01), Okumura et al.
patent: 5432176 (1995-07-01), Walser
patent: 5434292 (1995-07-01), Saita et al.
patent: 5436009 (1995-07-01), Jauw et al.
patent: 5437994 (1995-08-01), Emerson et al.
patent: 5446070 (1995-08-01), Mantelle
patent: 5460821 (1995-10-01), Masiz
patent: 5478814 (1995-12-01), Packman
patent: 5589480 (1996-12-01), Elkhoury et al.
patent: 5618557 (1997-04-01), Wille et al.
patent: 5645854 (1997-07-01), Masiz
patent: 5646151 (1997-07-01), Kruse et al.
patent: 5667773 (1997-09-01), Farrar et al.
patent: 5686106 (1997-11-01), Kelm et al.
patent: 5688955 (1997-11-01), Kruse et al.
patent: 5744458 (1998-04-01), Kruse et al.
patent: 5760023 (1998-06-01), Farrar et al.
patent: 5763445 (1998-06-01), Kruse et al.
patent: 5798093 (1998-08-01), Farrar et al.
patent: 5811078 (1998-09-01), Maycock et al.
patent: 5849761 (1998-12-01), Yaksh
patent: 5849762 (1998-12-01), Farrar et al.
Abbott, "Peripheral and central antinociceptive actions of ethylketocyclazocine in the formalin test." Eur. J. Pharmacol. 142:93-100 (1988).
Adelstein, Gilbert W., et al., "3,3-Diphenyl-3-(2-alkyl-1,3,4-oxadiazol-5-yl)propylcycloalkylamines, a Novel Series of Antidiarrheal Agents," Journal of Medicinal Chemistry, 19:1221-1225 (1976).
Alreja, et al., The formalin test: A tonic pain model in the primate, Pain, 20:97-105 (1984).
Andreev et al., "Opoids suppress spontaneous activity of polymodal nociceptors in rat paw skin induced by ultraviolet radiation." Neuroscience 58(4):793-798 (1994).
Ansel et al., "Cytokine modulation of keratinocyte cytokines", J. of Inv. Derm. 94(6):101-107 (1990).
Antonijevic, et al., Perineurial defect and peripheral opioid analgesia in inflammation, J. Neurosci., 15(1):165-172 (1995).
Awouters et al., "Loperamide: Survey of studies on mechanism of its antidiarrheal activity." Digestive Diseases and Sciences 38(6):977-995 (1993).
Awouters et al., "Pharmacology of antidiarrheal drugs." Ann. Rev. Pharmacol. Toxicol. 23:279-301 (1983).
Berrebi et al., "Varapamil inhibits B-cell-proliferation and tumor necrosis factor release and induces a clinical response in B-cell chronic lymphocytic leukemia", Leukemia 8(12):2214-2216 (1994).
Bianchi and Goi, "On the antidiarrheal and analgesic properties of diphenoxylate difenoxine and loperamide in mice and rats." Arzeneimittel-Forschung/Drug Research 27(1),5,1040-1043 (1977).
Buerkle et al., "Comparison of the spinal actions of the .mu.-opioid remifentanil with alfentanil and morphine in the rat", Anesthesiology 84(1):94-102 (1996).
Burkhardt et al., "Metkephamid (Tyr-D-Ala-Gly-Phe-N(Me)Met-NH.sub.2), a potent opoid peptide: Receptor binding and analgesic properties." Peptides 3:869-871 (1982).
Chemical Abstr. 121:57079d (1994), citing Park et al., "Synthesis of caspicinoids: 3-nitrogen-substituted phenylacetamides", Korean J. Med. Chem. 3(2): 142-147 (1993).
Chemical Abstr. 96:20297n (1982), citing Belgian Patent BE 886,579 (Jun. 10, 1981).
Chemical Abstr. 100:17470j (1984), citing lizuka et al., "Pharmacodynamics of a new antidiarrheic nufenoxole", Jitchuken Zenrinsho Kenkyho 9(1): 19-41 (1983).
Chemical Abstr. 82:156117x (1975), citing Ger. Offen. DE 2,440,541 (Mar. 6, 1975).
Chemical Abstr. 120:289632m (1994), citing Park et al., Pain reducing effects of 4-amino and 4-(1-piperazinyl) phenylacetamide derivatives, Korean J. Med. Chem. 3(2): 116-23 (1993).
Chemical Abstr. 105:208764w (1986), citing Ger. Offen. DE 3,545,981 (Jan. 7, 1985).
Chemical Abstr. 120:116860f (1994), citing Japanese patent JP 05,286,851 (Nov. 2, 1993).
Cortes, et al., Tape stripping-induced hyperalgesia as a model for the evaluation of analgesic agents, Soc. Neurosci. Abstr., 22:1315 (1996).
D'Amour et al., "A method for determining loss of pain sensation." J. Pharmacol. Exp. Ther. 72:74 (1941). binding to opoid receptors in rat and human small intestine." The International Narcotics Research Conference (INRC) '89, Alan R. Liss, Inc., pp. 165-169 (1990).
DeHaven-Hydkins et al., ADL 2-1294, a peripherally selective opiate analgesic, Society for Neuroscience Abstracts 22 (1-3): 1362 (1996).
Database, Derwent Publication 199236, citing patent # 9213540, Analgesic ointment contg. cocaine or novacaine--together with menthol and salicylate ester.
Dubuisson, et al., The formalin t

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Screening methods for cytokine inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Screening methods for cytokine inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening methods for cytokine inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1171828

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.